Suk Ji-Woo, Poppert Cordts Katrina M, Garvey William, Lerdahl Arica, Soltis-Vaughan Brigette, Bohn Alexandra, Edwards Ryan, Blair Robert James, Hwang Soonjo
Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE, United States.
Child and Adolescent Mental Health Centre, Mental Health Services, Capital Region of Denmark, Copenhagen, Denmark.
Front Psychiatry. 2022 Apr 6;13:742148. doi: 10.3389/fpsyt.2022.742148. eCollection 2022.
To investigate the utility of dimensional psychopathologies of disruptive mood and behavior disorders (DBDs) by applying latent profile analysis (LPA) for characterization of youth referred to the tertiary outpatient clinic of child and adolescent psychiatry clinic and pharmacological treatment choices. One hundred fifty-eight children and adolescents with significant DBDs symptoms participated. Core dimensional psychopathologies of DBDs (irritability, callous-unemotional trait, and reactive-proactive aggressive behavior), DSM diagnoses, prescribed medications, and behavioral and emotional problems (Child Behavior Checklist, CBCL) were measured at baseline (clinic intake) and at 3-month follow-up. Latent Profile Analysis (LPA) was applied to characterize the study population based on the levels and interrelations among the core dimensional DBDs psychopathologies. Following LPA, the differences in clinical and treatment features between the latent classes were analyzed. LPA revealed two latent classes based on severity of DBDs symptoms. Class 1 (the moderate group) was characterized by relatively low scores on all trans-diagnostic indicators, whereas class 2 (the severe/critical group) showed higher levels of the dimensional psychopathologies and the majority of CBCL subscales. In addition, the severe/critical group was more often prescribed antipsychotic medications, and also experienced more frequent medication changes (addition, increasing the dose, and trial of different medications). Our findings suggested that application of LPA to a cluster of dimensional DBDs psychopathologies may provide valuable characterization of the youths referred to a tertiary outpatient child and adolescent psychiatric clinic, and offer insight into the providers' decision making on psychotropic medications, by overall severity of these psychopathologies rather than by single categorical diagnosis or single externalizing psychopathology.
通过应用潜在类别分析(LPA)来研究破坏性行为和情绪障碍(DBDs)的维度性精神病理学特征,以对转至儿童和青少年精神病学三级门诊的青少年进行特征描述,并指导药物治疗选择。158名有明显DBDs症状的儿童和青少年参与了研究。在基线(门诊初诊)和3个月随访时,测量了DBDs的核心维度性精神病理学特征(易怒、冷酷无情特质和反应性-主动性攻击行为)、DSM诊断、处方药物以及行为和情绪问题(儿童行为量表,CBCL)。应用潜在类别分析(LPA),根据核心维度性DBDs精神病理学特征的水平和相互关系,对研究人群进行特征描述。在LPA之后,分析了潜在类别之间临床和治疗特征的差异。LPA根据DBDs症状的严重程度揭示了两个潜在类别。第1类(中度组)的特征是所有跨诊断指标得分相对较低,而第2类(重度/临界组)的维度性精神病理学特征和大多数CBCL子量表得分较高。此外,重度/临界组更常被处方使用抗精神病药物,并且药物更换也更频繁(加用、增加剂量以及试用不同药物)。我们的研究结果表明,将LPA应用于一组维度性DBDs精神病理学特征,可能为转至儿童和青少年精神病学三级门诊的青少年提供有价值的特征描述,并有助于了解医疗服务提供者在精神药物治疗决策方面的情况,依据的是这些精神病理学特征的总体严重程度,而非单一的分类诊断或单一的外化性精神病理学特征。